VistaGen Therapeutics logo
VistaGen Therapeutics VTGN
$ 2.52 -0.59%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

VistaGen Therapeutics ROCE Ratio 2011-2024 | VTGN

Annual ROCE Ratio VistaGen Therapeutics

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-28.89 -490.63 -14.18 -10.12 -693.14 -219.04 -144.6 -437.1 2217.69 39.59 101.76 443.14 318.4 -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
2217.69 -693.14 83.3

Quarterly ROCE Ratio VistaGen Therapeutics

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-34.52 -98.23 -119.39 -157.81 -191.02 -128.59 -152.82 -126.94 -110.05 -91.38 -73.12 -65.58 -36.98 -40.65 -134.77 -378.87 -650.72 -748.11 -756.04 -636.4 -495.67 -477.5 -411.0 -303.75 -848.78 -902.67 -957.55 -1001.21 -370.55 -256.06 84.27 2546.11 3111.18 3505.44 3272.16 886.81 389.37 58.93 74.0 106.18 139.88 167.95 169.91 212.4 237.66 234.05 174.02 245.57 219.84 221.66 260.42 50.39 46.8 6.39

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
3505.44 -1001.21 104.9